APA (7th ed.) Citation

Hyo Jeong Lee, Pyeonghwa Jeong, Yeongyu Moon, Jungil Choi, Jeong Doo Heo, Yong-Chul Kim, & Sun-Young Han. (2021). Characterization of LDD-2633 as a Novel RET Kinase Inhibitor with Anti-Tumor Effects in Thyroid Cancer. MDPI AG.

Chicago Style (17th ed.) Citation

Hyo Jeong Lee, Pyeonghwa Jeong, Yeongyu Moon, Jungil Choi, Jeong Doo Heo, Yong-Chul Kim, and Sun-Young Han. Characterization of LDD-2633 as a Novel RET Kinase Inhibitor with Anti-Tumor Effects in Thyroid Cancer. MDPI AG, 2021.

MLA (9th ed.) Citation

Hyo Jeong Lee, et al. Characterization of LDD-2633 as a Novel RET Kinase Inhibitor with Anti-Tumor Effects in Thyroid Cancer. MDPI AG, 2021.